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An interlaboratory study using matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS)
to determine the identification of clinically important yeasts (n 35) was performed at 11 clinical centers, one company, and
one reference center using the Bruker Daltonics MALDI Biotyper system. The optimal cutoff for the MALDI-TOF MS score was
investigated using receiver operating characteristic (ROC) curve analyses. The percentages of correct identifications were com-
pared for different sample preparation methods and different databases. Logistic regression analysis was performed to analyze
the association between the number of spectra in the database and the percentage of strains that were correctly identified. A total
of 5,460 MALDI-TOF MS results were obtained. Using all results, the area under the ROC curve was 0.95 (95% confidence inter-
val [CI], 0.94 to 0.96). With a sensitivity of 0.84 and a specificity of 0.97, a cutoff value of 1.7 was considered optimal. The overall
percentage of correct identifications (formic acid-ethanol extraction method, score> 1.7) was 61.5% when the commercial
Bruker Daltonics database (BDAL) was used, and it increased to 86.8% by using an extended BDAL supplemented with a Cen-
traalbureau voor Schimmelcultures (CBS)-KNAW Fungal Biodiversity Centre in-house database (BDALCBS in-house). A
greater number of main spectra (MSP) in the database was associated with a higher percentage of correct identifications (odds
ratio [OR], 1.10; 95% CI, 1.05 to 1.15; P< 0.01). The results from the direct transfer method ranged from 0% to 82.9% correct
identifications, with the results of the top four centers ranging from 71.4% to 82.9% correct identifications. This study supports
the use of a cutoff value of 1.7 for the identification of yeasts using MALDI-TOF MS. The inclusion of enough isolates of the same
species in the database can enhance the proportion of correctly identified strains. Further optimization of the preparation meth-
ods, especially of the direct transfer method, may contribute to improved diagnosis of yeast-related infections.
Fast and reliable identification of causative agents of fungal in-fections is important, as this contributes to the choice of ap-
propriate antifungal treatment in order to provide the best possi-
ble management of patients. Conventional procedures for the
identification of pathogenic microorganisms in clinical microbi-
ology laboratories are rapidly being replaced by matrix-assisted
laser desorption ionization–time of flight mass spectrometry
(MALDI-TOF MS)-based methods. In comparison with other
identification methods, such as sequence analysis of the D1/D2
domains of the large subunit ribosomal DNA (rDNA) and the
internal transcribed spacer (ITS) 1 and 2 regions of the rDNA,
MALDI-TOFMS is able to provide accurate identifications of mi-
croorganisms with a short turnaround time (1, 2). No major er-
rors, such as genus-level misidentifications, have been reported in
many MALDI-TOF MS-based studies on yeasts and filamentous
fungi (3–11). Most yeasts can easily be processed and correctly
identified; even sibling species that cannot be distinguished with
common biochemical methods can be discriminated with
MALDI-TOF MS (12, 13).
Currently, the MALDI-TOF MS approach is commercialized
by a number of manufacturers: MALDI Biotyper (Bruker Dalton-
ics, Germany), Vitek MS (bioMérieux, France), Axima (Shi-
madzu)-Saramis, and Andromas (Andromas, France) (14–20).
Some studies have directly or indirectly compared the preparation
methods currently used, but these studies were done by a single
laboratory only (2, 3, 18). Cassagne et al. (2) compared four sam-
ple preparation methods and concluded that the formic acid-eth-
anol extractionmethod is preferred for use in clinical laboratories.
The two other studies (3, 18) compared two MALDI-TOF MS
systems (Bruker and Andromas) using the procedures recom-
mended by the respectivemanufacturers. Both concluded that the
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platforms performed equally well for yeast identification and out-
performed traditional identification methods.
In previous studies, the sensitivity and specificity of the iden-
tification results of yeasts are variable and difficult to compare
between laboratories, as they used different sample preparation
methods. The percentages of correct identifications ranged from
16% (21) and 21.3% (2) with direct transfer to90%with formic
acid-ethanol extraction (22–24).
Here, we present results from a multicenter European inter-
laboratory study in which the performance of the MALDI Bio-
typer (Bruker) was investigated regarding the identification of
yeasts in a clinical setting, comparing three methods of sample
preparation, and using the Bruker commercial database and an
expanded database (Bruker Daltonics database plus the Centraal-
bureau voor Schimmelcultures in-house [BDALCBS in-
house]). Moreover, the optimal cutoff values and the number of
entries in the database with respect to the number of correct iden-
tifications were evaluated.
(This work was presented in part during the 6th Congress on
Trends inMedical Mycology (TIMM-6), Copenhagen, Denmark,
11 to 14 October 2013, and during the Annual Scientific Spring
Meeting organized by the Dutch Society of Medical Microbiology
(NVMM) and the Royal Dutch Society ofMicrobiology (KNVM),
Arnhem, the Netherlands, 15 to 16 April 2014.)
MATERIALS AND METHODS
Strains and sample preparation for MALDI-TOF MS analysis. Eleven
clinical centers, comprising eight academic and three general hospitals,
one company (Bruker Daltonics, Bremen, Germany), and one reference
center (CBS-KNAW) participated in this study. A blinded heterogeneous
set of 35 reference strains was selected from the CBS-KNAW yeast collec-
tion, comprising common and rare yeast human pathogens as well as
strains phylogenetically related to pathogenic species but known to be
nonpathogenic (see Table S1 in the supplemental material). Twenty-two
out of 35 strains were ascomycetous yeasts and 13 were basidiomycetous
yeasts. The identifications of all strains were verified by sequence analyses
of internal transcribed spacers (ITS) 1 and 2 and the D1/D2 regions of
large subunit ribosomal DNA (rDNA) (see Table S1) (12, 25). All strains
were different from those present in the commercial (BDAL) database,
but in an extended (BDALCBS in-house) database reference, the MSP
of seven out of the 35 send strains were present (see Table S1). As a
control, the set also included a species that had no reference mass spectra
in either database (see Table S1). The strains were cultured on Sab-
ouraud’s dextrose agar (SDA) plates and incubated for 48 h at 30°C and
prepared for shipment on SDA agar slants to the participating laborato-
ries. As reported by the participating laboratories (see Table S2 in the
supplemental material), the growth of strains forMALDI testing was usu-
ally sufficient after 24 h.
Sample preparation was carried out according to the Bruker protocols
using three methods: (i) direct transfer (DT), (ii) extended direct transfer
(eDT), and (iii) ethanol (EtOH)-formic acid (FA) extraction. In the DT
method, a thin smear of biological material was placed onto a target plate,
which was immediately overlaid with 1 l of alpha-cyano-4-hydroxycin-
namic acid matrix solution (HCCA) (Bruker Daltonics, Germany), pre-
pared according to the protocol of the manufacturer. In the eDTmethod,
the biomasswas treatedwith 1l of 70%FAon the target plate prior to the
HCCAmatrix overlay. In the EtOH-FAmethod, one or two loops of yeast
biomass (1 l volume, sterile inoculation loop) was used for the crude
protein extraction, as described previously (16, 17). One microliter of the
crude protein extract was spotted onto the target plate, and after air-
drying, it was overlaid with 1 l of HCCA matrix solution. For all meth-
ods, each tested strain was spotted in duplicate.
Commercial and extended databases for MALDI-TOF MS analysis.
Two versions of the standard commercially available Bruker Daltonics
database (BDAL)were used in this study (see Table S2 in the supplemental
material). The first version (version 3.1.2.0) included 3,995 main spectra
(MSP) and was used by six labs, and the second version (version 3.2.1.1),
with 4,110MSP, was used by seven labs. The yeast panel BDALwith 4,110
MSP contained an additional 20MSP of 18 species belonging to 11 genera
(see Table S3 in the supplemental material). Four hundred forty-seven
yeast strains representing 104 species were selected from the CBS-KNAW
collection to create an extended database, namely, BDAL supplemented
with a CBS in-house database (BDALCBS in-house), consisting of 510
reference MSP. Ethanol extracts of those yeast strains cultivated on SDA
were sent to Bruker Daltonics (Bremen, Germany) to create MSP accord-
ing to the manufacturer’s standard operating procedures. Each of 510
MSP was generated from 22 to 24 individual spectra using the MALDI
Biotyper automated FlexControl software version 3.0 (Bruker Daltonics).
Additionally, in theCBS in-house database, theMSPof someCryptococcus
neoformans strains were included from growth on media that reduced
capsule formation, namely, SDA plus 0.5 M NaCl. The CBS in-house
database was made available to all participating laboratories.
The MALDI-TOFMS identification results were automatically classi-
fied using the log-score values generated by theMALDI Biotyper software
(Bruker Daltonics, Germany), performed according to the manufactur-
er’s instructions. Each laboratory received six Microsoft Office Excel files
with premade tables to report the data of the MALDI-TOF MS-based
identification results, comprising the 1st best-matched organism identity
and score value for spots 1 and 2, per three methods and per two data-
bases.When the final overview of the participating laboratories wasmade,
each laboratorywasmarked blindly with a numeric code, and the raw data
were distributed to all participants.
Data analyses. A receiver operating characteristic (ROC) curve was
plotted in order to investigate different MALDI-TOF MS score cutoff
values. This analysis was performed using all data and repeated using only
the results from the full extraction method and extended database analy-
sis. Based on the sensitivities and specificities for different cutoff values
(i.e., 2.0, 1.9, 1.8, 1.7, and 1.6), the most optimal cutoff value was deter-
mined.
Based on the optimal cutoff value, the percentages of correct identifi-
cation were compared between those from the commercial (BDAL) and
extended (BDALCBS in-house) databases, both for the overall results
and those per participating laboratory. Using the results from the EtOH-
FA-extraction (Ex) protocol, the association between the number of MSP
per strain included in the extended (BDALCBS in-house) database and
the proportion of correct identifications of strains were analyzed. The
percentages of correct identifications were also compared between the
three different sample preparation methods using either one spot or du-
plicate spots.
The results for continuous variables are expressed as the mean with
standard deviation (SD) or as the median with interquartile range (IQR)
when not normally distributed, and for categorical variables, they were
expressed as percentages with the absolute number. The summary data
were calculated using Student’s t test (normal distribution) or Mann-
Whitney U test (skewed distribution) for continuous variables and by
chi-square analysis for categorical variables. Logistic regression analysis
was used to calculate the association between correct MALDI-TOF MS
identification and the number ofMSP included in the database. Statistical
analyses were performed with SPSS version 21.0 (Windows, Chicago, IL,
USA).
RESULTS
Determination of an interpretative cutoff value for yeast species
identification by MALDI-TOF MS. In total, 5,460 MALDI-TOF
MS results were available for analysis in principle (13 laboratories,
35 strains, 2 databases, 3 extractionmethods, and 2 spots; Table 1).
Using all 5,460 results, the area under the ROC curve (AUC) was
Vlek et al.
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0.95 (95% confidence interval [CI], 0.94 to 0.96). The sensitivity
values ranged from 0.50 (with 2.0 cutoff) to 0.89 (with 1.6 cutoff),
and the specificities were between 0.89 (with 1.6 cutoff) and 0.99
(with 2.0 cutoff) (Table 2). A cutoff value of 1.7 showed a sensi-
tivity of 0.84 and a specificity of 0.97 and was considered the most
optimal cutoff value. When the analysis was repeated using only
the results from the extended (BDALCBS in-house) database
and the full extraction method (n 910), as these gave the most
consistent and high scores in all labs, a cutoff of 1.7 led to 90.6%of
the results showing scores above the cutoff value, of which 99.3%
were correctly identified and 0.7% were incorrect (0.5% errors at
the species level and 0.2% errors at the genus level), resulting in a
sensitivity of 0.97 and a specificity of 0.90 (AUC, 0.98; 95% CI,
0.96 to 1.00). Errors at the species level were with aCandida viswa-
nathii strain that was identified as Candida tropicalis, a Cryptococ-
cus gattii strain identified as Cryptococcus curvatus, and a
Kodamaea ohmeri strain identified as Candida guilliermondii (2
times). One time, a Cryptococcus neoformans strain was misiden-
tified at the genus level as C. guilliermondii.
The cutoff of 1.7 was used for all further analyses, for which
MALDI-TOF MS results were categorized as correct identifica-
tion, no correct identification, no peaks found, or not performed/
missing (Table 1).
MALDI-TOF MS identification results obtained with com-
mercial and extended databases. From all 35 strains tested, the
species least often correctly identified when the MALDI-TOF MS
EtOH-FA-Ex protocol and extended (BDALCBS in-house) da-
tabase were used wereMalassezia pachydermatis (correct identifi-
cation, 53.8%), C. viswanathii (correct identification, 69.2%), C.
curvatus (correct identification, 69.2%), andCryptococcus adelien-
sis (correct identification, 69.2%). ForCryptococcus amylolentus, a
close relative ofC. neoformans andC. gattii that is not represented
in the commercial (BDAL) or extended (BDALCBS in-house)
databases, only nonreliable identifications (NRIs) were achieved,
with scores of1.6, indicating that theMALDI-TOFMSBiotyper
system did not provide false-positive identifications with scores of
1.7 for this species.
When analyzing the results generated with the commercial
(BDAL) and extended (BDALCBS in-house) databases, the
highest number of correct and reliable identifications was ob-
served when the extended (BDALCBS in-house) database was
applied, independent of the sample preparation procedure
used. The overall percentage of correct identification using the
commercial (BDAL) database was 61.5%, versus 86.8% with the
extended (BDALCBS in-house) database (full extractionmethod).
Although the proportion of correct identifications differed be-
tween laboratories, all laboratories showed an increase in cor-
rect identifications using the extended (BDALCBS in-house)
database compared to that with the commercial (BDAL) data-
base (Table 3).
In addition, the association between the number of MSP of
strains in the extended (BDALCBS in-house) database and the
results of MALDI-TOF MS identification was evaluated. Strains
that were correctly identified by MALDI-TOF MS were repre-
sented by a median of 11 (IQR, 5 to 31) strains in the database,
compared to a median of 2 strains (IQR, 1 to 6) for those not
correctly identified (P  0.01). The number of MSP in the data-
base was significantly associated with a correct MALDI-TOF MS
identification (odds ratio [OR], 1.10; 95% CI, 1.05 to 1.15; P 
0.01).
MALDI-TOF MS identification results obtained with differ-
ent sample preparations. The proportions of correct identifica-
tions with the use of the extended database were 39.8%, 68.1%,
and 86.8% when using three sample preparation methods,
TABLE 1 Interpretation of MALDI-TOF MS results
Conclusions made Identification result(s)
No. of
identifications
Results leading to final and correct
identification
Correct identification (species level) with score of2.0 1,550
Correct identification (species level) with score of 1.7–2.0 993
Correct identification of species complex with score of1.7 17
Results not leading to final and
correct identification
Score of1.7, correct identification (species level) 450
Not reliable identification with score of1.7 545
No peaks found 755
Correct identification of species complex with score of1.7 33
Incorrect identification (species or genus level) with score of 1.7–2.0 14
Incorrect identification (species or genus level) with score of2.0 6
Not performed or missing value No growth 109
Not performed 680
Correct identification (species level), but species not available in database 27a
Incorrect identification (species level) with score of1.7, species not
available in database
8
Incorrect identification (species level) with score of1.7, species not
available in database
273
a Most likely the use of the wrong database.
TABLE 2 Sensitivities and specificities according to different MALDI-
TOF MS cutoff values using all MALDI-TOF MS results (n 5,460)
Cutoff value Sensitivity Specificity
1.6 0.89 0.89
1.7 0.84 0.97
1.8 0.75 0.98
1.9 0.64 0.99
2.0 0.50 0.99
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namely, DT, eDT, and EtOH-FA, respectively. However, large dif-
ferences in performance occurred between the laboratories, espe-
cially for DT, with only four laboratories delivering high rates of
correct identification (71.4% to 82.9%) using this method (Table
4). When only those species known to be most often identified
from clinical samples (i.e., Candida albicans and Candida
glabrata) were considered for the analysis, DT, eDT, and
EtOH-FA led to correct identification in 46.2%, 75.4%, and 98.5%
of the strains, respectively.
When the direct or extended direct transfer method was per-
formed on two spots in the first step, in 52.1% and 24.0% of the
strains, respectively, no identification is available, which requires
proceeding with the EtOH-FA method. When the EtOH-FA
method is performed using duplicates, a correct identificationwill
be available in 88.6% of strains, leaving 11.4% without MALDI-
TOF MS identification (Table 5).
DISCUSSION
In this multicenter study, we evaluated the usefulness and perfor-
mance of the MALDI-TOF MS Biotyper for identifying yeast iso-
lates in clinical laboratories across Europe using the commercial
Bruker database (BDAL) and an expanded (BDALCBS in-
house) database that included an additional 510 MSP of yeast
species. As it is preferred to avoid the laborious full extraction
procedure in a clinical lab if direct transfer or extended transfer
delivers the same results, we also compared different sample prep-
aration methods.
Based on this study, the effect of applying a lower cutoff score
was evaluated, and a cutoff value of 1.7 was considered appropri-
ate for routine yeast identification in clinical laboratories. The
majority of misidentifications were associated with scores of1.7
(nonreliable identification [NRI]), regardless of the sample prep-
aration method and database used. This is in agreement with pre-
vious studies that reported an increase in the number of accurate
identifications at the species level when lowering the score thresh-
old to a value of 1.7 or 1.8 (6, 12, 26–28). These studies showed
88.7% (27) and 96% correct identification rates with a score of
1.7 (21), compared to 97.4% (29) and 97.9% (30) with a score of
1.8. The Bruker MALDI Biotyper system did not generate erro-
neous fungal identifications (10, 31).
This study showed the usefulness of database expansion for
reliably identifying emerging rare pathogenic yeast species. Also,
the identification of commonly found yeasts improved by adding
MSP, most likely because a higher number of reference MSP per
species increased the biological diversity of the database. This is in
agreement with recent studies that showed that creating an in-
house library of previously accurately identified reference strains
(e.g., determined by rDNA sequencing) improved fast and reliable
identification of strains (2, 4, 8, 9, 13, 18, 29). Some recent single-
laboratory-based studies reported that the simultaneous use of
commercial and in-house databases allowed rapid and correct
identification of yeast isolates confirmed by molecular identifica-
tion (8–10). The results of Kolecka et al. (9) indicated that a self-
established database forMalassezia species improved the identifi-
cation capability of MALDI-TOF MS for diagnosing skin
pathogens. An in-house database of arthroconidial yeasts (e.g.,
Trichosporon, Geotrichum, and Saprochaete spp.) improved the
number of correct identifications at the species level (8). Taj-Al-
deen et al. (32) showed 100% correct identifications by MALDI-
TOF MS of 68 C. albicans isolates and 133 isolates of other Can-T
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dida spp. and uncommon yeasts from bloodstream infections,
with scores of 1.9 using the extended (BDALCBS in-house)
database used in the present study. De Carolis et al. (10) suggested
that the improvement of sample processing by combined DT and
EtOH-FAmethods led to improved identifications of yeasts when
the samemethodwas used for the in-house database construction.
In that study, a correct identification rate of 95.5%was obtained at
the species level, and 4.5% were not identified with a cutoff value
of 2.0 during the first run (10).
From a clinical perspective, it is important to know which
method is preferred to obtain a reliable identification andwhether
one ormore spots have to be used per tested strain. Our data show
that when theDT, eDT, or EtOH-FAmethod is performed on two
spots, the correct identification rates are 47.9%, 76%, and 88.6%,
respectively.We also calculated that when only one spot per strain
is available for identification, the correct identification rates are
lower, namely, 38.9%, 67.1%, and 84.7%, by the DT, eDT, and
EtOH-FAmethods, respectively. Themost recent evaluation of an
eDT method for routine yeast identification by Gorton et al. (28)
suggested that lowering the cutoff value from 2.0 to 1.9 allowed
successful identification to the species level for 90% of isolates,
with 7.4% of the isolates identified to the genus level only, while
2.6% remained unidentified after the first attempt. Dhiman et al.
(27) suggested that when using only a single spot for the EtOH-FA
method, only 6.8% or 1.4% of yeast isolates would require addi-
tional testing, depending on the cutoff values selected (2 or
1.8, respectively). Stevenson et al. (29) applied yeast strains in
quadruplicate and showed that 89.6% and 97.4% of the isolates
were correctly identified on the first run and within the first two
spots, respectively. They recommend to use duplicates to retest
strains if their spectral scores were1.8. Our data indicated pre-
liminary yet promising application of the DT method for routine
yeast identification, as appealing results were delivered by four
laboratories using this method. Obviously, further optimization
of thismethod is needed before it can be applied in all laboratories.
Optimization may need to focus especially on the amount of cells
used on the target plate, which may also differ between groups of
yeasts.
Previous studies reported that discordant yeast identifications
were observed mainly at the species level and only when compar-
ing results from conventional biochemical methods with those
obtained by MALDI-TOF MS (12, 14, 27). Discordant results re-
quire confirmation by molecular identification methods, e.g., se-
quencing of ribosomal DNA, to resolve problematic identifica-
tions. This is also true for obtaining a conclusive identification of
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(6)
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T
C
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(23)
0.0
(0)
77.1
(27)
82.9
(29)
77.1
(27)
45.7
(16)
65.7
(23)
71.4
(25)
54.3
(19)
91.4
(32)
68.6
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N
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(0)
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(1)
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0.0
(0)
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(0)
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(5)
0.0
(0)
0.0
(0)
0.0
(0)
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(0)
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(0)
17.1
(6)
10.3
(47)
E
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H
-FA
C
orrect
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91.4
(32)
91.4
(32)
94.3
(33)
88.6
(31)
82.9
(29)
91.4
(32)
94.3
(33)
62.9
(22)
94.3
(33)
71.4
(25)
88.6
(31)
94.3
(33)
82.9
(29)
86.8
(395)
N
ot
perform
ed
0.0
(0)
2.9
(1)
0.0
(0)
2.9
(1)
0.0
(0)
0.0
(0)
0.0
(0)
0.0
(0)
0.0
(0)
2.9
(1)
0.0
(0)
0.0
(0)
17.1
(6)
2.0
(9)
a
D
T
,direct
tran
sfer;eD
T
,exten
ded
direct
tran
sfer;E
tO
H
-FA
,eth
an
ol-form
ic
acid
extraction
.
b
ID
,iden
tifi
cation
.
TABLE 5 Percentage of correct identification per extraction method
using 1 or 2 duplicates (based on the extended database [BDALCBS
in-house], strains not performed, or no growth excluded)
Extraction
methoda
% correct identifications by no. of spots, selectionb:
1, worst case 1, best case 1, mean 2
DT 29.9 47.9 38.9 47.9
eDT 58.2 76.0 67.1 76.0
EtOH-FA 80.7 88.6 84.7 88.6
a DT, direct transfer; eDT, extended direct transfer; EtOH-FA, ethanol-formic acid
extraction.
b Worst-case scenario, the single spot that was selected is the worse of the 2 results
generated; best-case scenario, the single spot that was selected is the better of the 2
results generated.
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strains that were identified with score values of1.7 that did not
allow a reliable identification or that were not identified (i.e., no
peaks found). To our knowledge, no study has reported misiden-
tification of yeast isolates with highMALDI-TOFMS scores. Cas-
sagne et al. (2) reported thatC. neoformans isolates were not iden-
tified using the DT and eDT methods, while identification
succeeded when the EtOH-FA method was applied. In this study,
one laboratory failed to correctly identify C. curvatus CBS 570T
using the eDTmethod. The strain was misidentified as the nonre-
lated Cryptococcus uniguttulatus, with scores of 2.258 in both da-
tabases, and we speculate that this may be caused by a mix-up of
the isolate samples.
In conclusion, this multicenter study indicates that MALDI-
TOF MS is a reliable system for identifying commonly occurring
clinically relevant and more rare emerging yeast pathogens. Low-
ering the cutoff value to 1.7 is suggested for routine yeast identi-
fication at the species level. Differences in the methods used for
sample preparation and the choice of databases have a significant
impact on the accuracy of identifications in routine laboratory
practice. In the future, further studies are needed to optimize the
DTmethod, as this will greatly benefit routine practice in diagnos-
tic (clinical) microbiology laboratories.
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